Clinical Trials Browser

Phase 1 × Uterine Cervical Neoplasms × Papillomavirus Vaccines × Clear all

NCT03900572 2023-04-13

A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

Phase 1 Completed

Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

NCT05680454 2023-01-17

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Phase 1 Completed

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT00541970 2018-08-17

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

Phase 1 Completed

961 enrolled 43 charts

Uterine Cervical Neoplasms, Virus Diseases, Papillomavirus Infections